Recode Studios IPO Day 2: GMP ₹37

Welcome back to our daily deep dive into the Recode Studios SME IPO! As we enter Day 2 of its subscription period, the excitement, or perhaps the cautious observation, continues. The IPO, which opened its doors for investors on May 5th, 2026, and will close on May 7th, 2026, is offering shares at an issue price of ₹158. While the official subscription numbers are still trickling in, we’re here to break down what we know so far and what it might mean for your investment decisions.

Subscription Status

As of Day 2, it’s interesting to note that the subscription figures for Recode Studios IPO are currently showing 0x across all categories – Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). This might seem unusual, but it’s not uncommon, especially in the early stages of an SME IPO. Often, the bulk of subscriptions, particularly from retail investors, tend to pour in on the final day. This lack of immediate oversubscription doesn’t necessarily signal a lack of interest; it could simply mean investors are waiting for more data or to gauge the overall market sentiment before committing their funds. However, the absence of any bids from QIBs and NIIs, who are typically early movers, is something to keep an eye on. Their participation is often a strong indicator of institutional confidence in the company’s prospects.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Recode Studios IPO stands firm at ₹37. This is the same as yesterday’s GMP, indicating stability in the market’s current valuation of the stock. With an issue price of ₹158 and a GMP of ₹37, the expected listing price is around ₹195 (₹158 + ₹37). This projected listing gain of approximately 23.4% (₹37 / ₹158 * 100) is quite attractive. The stability in GMP, despite the zero subscription numbers, suggests that market participants are holding their ground, perhaps anticipating a surge in subscriptions as the closing date approaches. It’s a positive sign that the GMP hasn’t dipped, which is always a concern when subscription numbers are low.

Should You Apply?

So, the big question remains: should you be applying for the Recode Studios IPO? On one hand, the GMP is offering a promising potential listing gain, and the stability in GMP is encouraging. The issue price of ₹158 and the expected listing of ₹195 present a decent opportunity. However, the current zero subscription across all categories is a point of caution. It’s crucial to remember that GMP is an unofficial indicator and is subject to change. The SEBI advisor always recommends thorough research into the company’s fundamentals, financials, and future prospects before making any investment decision. While the GMP paints a rosy picture, the lack of subscription momentum on Day 2 warrants a wait-and-watch approach for many. You might want to monitor the subscription levels closely on Day 3. If you’re a risk-taker and believe in the company’s long-term vision, and the GMP continues to hold strong, it could be worth considering. But for the more conservative investor, it might be prudent to wait for more concrete subscription data to emerge.

View Full Recode Studios IPO Details